C3 nephritic factor (C3NeF) is an autoantibody against the C3 convertase wh
ich stabilizes this otherwise inherently labile neoenzyme and induces a con
tinuous activation of the alternative pathway with C3 depletion. NeF is fou
nd in patients with membranoproliferative glomerulonephritis and/or partial
lipodystrpohy. NeF activity is usually detected in plasma by hemolytic tes
ts. In order to obtain reproducible data for the functional activity of pur
ified C3NeF IgG a solid phase assay was developed. C3 convertase was genera
ted on immobilized C3b by incubation with factors B and D in the presence o
f Ni2+. Convertase sites were left to decay in the presence of normal IgG o
r NeF IgG. Residual convertase activity was measured by adding I-125-C3 and
capturing nascent I-125-C3b on the plate surface via covalently coupled NH
2-Glu-Tyr dipeptide, In the presence of factor H during C3 convertase decay
, a dose dependent stabilizing activity was shown for NeF IgG including NeF
IgG purified from urine. A second format of the assay was developed in whi
ch C3 convertase was assembled on C3b(2)-IgG complexes in the presence of M
g2+. Since these complexes are more efficient as convertase precursors the
signal was five-fold higher than with C3b. Convertase decay, on the other h
and, was not influenced by the nature of the precursor and in both systems
the stabilizing activity of NeF IgG was similar. (C) 2001 Elsevier Science
B.V. All rights reserved.